Total planned funding: $353,028,679
Allocations
Countries/Regions
| Eswatini | $353,028,679 |
Organizational Types
| Private Contractor | $93,889,927 |
| University | $62,630,611 |
| NGO | $62,497,191 |
| Unknown | $54,547,788 |
| Own Agency | $44,056,907 |
| FBO | $13,230,009 |
| Host Country Government Agency | $12,294,827 |
| Multi-lateral Agency | $7,202,970 |
| Other USG Agency | $2,678,449 |
| Implementing Agency | $0 |
Program Areas
| Care | $108,061,546 |
| Treatment | $88,672,533 |
| Prevention | $66,300,383 |
| Governance and Systems | $34,947,775 |
| Testing | $27,882,304 |
| Management and Operations | $27,164,138 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $71,127,758 |
| HBHC: Care: Adult Care and Support | $45,832,600 |
| HKID: Care: Orphans and Vulnerable Children | $36,360,996 |
| HVCT: Testing: HIV Testing and Counseling | $27,882,304 |
| HVMS: Management and Operations | $27,164,138 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $25,651,311 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,835,679 |
| HVTB: Care: TB/HIV | $17,381,840 |
| OHSS: Health Systems Strengthening | $15,462,946 |
| HVSI: Strategic Information | $12,760,602 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,692,939 |
| HTXD: Treatment: ARV Drugs | $10,078,150 |
| PDCS: Care: Pediatric Care and Support | $8,486,110 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,953,483 |
| PDTX: Treatment: Pediatric Treatment | $7,466,625 |
| HLAB: Laboratory Infrastructure | $6,724,227 |
| HMBL: Biomedical Prevention: Blood Safety | $1,166,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$53,197,235
Countries/Regions
Pact, Inc.:
$42,260,917
Countries/Regions
Not Available:
$36,087,922
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions